Related Experiment Video
Updated: Mar 7, 2026

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer
Published on: January 12, 2020
Downregulation of OCLN and GAS1 in clear cell renal cell carcinoma
André Luis Giacometti Conceição1, Camila Tainah Da Silva2, Rodolfo Miglioli Badial1
1Laboratory of Genomic Studies, Department of Biology, São Paulo State University (UNESP), São José do Rio Preto, SP 15054-000, Brazil.
Abstract:
Clear cell renal cell carcinoma (ccRCC) is the most common histological subtype of kidney cancer. This carcinoma is histologically characterized by the presence of clear and abundant cytoplasm. In the present study, we sought to identify genes differentially expressed in ccRCC and build a molecular profile of this cancer. We selected genes described in the literature related to cellular differentiation and proliferation. We analyzed the gene and protein expression by quantitative PCR (qPCR) and immunohistochemistry, respectively, and examined possible epigenetic mechanisms that regulate their expression in ccRCC samples and cell lines. Occludin (OCLN) and growth arrest-specific 1 (GAS1) genes were underexpressed in ccRCC, and we report that miR-122 and miR-34a, respectively, may regulate their expression in this cancer. Furthermore, we showed by qPCR and immunohistochemistry that solute carrier family 2 member 1 (SLC2A1) was significantly overexpressed in ccRCC. The set of genes identified in the present study furthers our understanding of the molecular basis and development of ccRCC.
Insights
Researchers identified key genes involved in clear cell renal cell carcinoma (ccRCC), a common kidney cancer. They found Occludin (OCLN) and Growth Arrest-Specific 1 (GAS1) genes are underexpressed, while Solute Carrier Family 2 Member 1 (SLC2A1) is overexpressed in ccRCC.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Clear cell renal cell carcinoma (ccRCC) is the predominant histological subtype of kidney cancer.
- ccRCC is characterized by abundant clear cytoplasm.
- Understanding the molecular underpinnings of ccRCC is crucial for developing targeted therapies.
Purpose of the Study:
- To identify genes differentially expressed in ccRCC.
- To construct a molecular profile of ccRCC.
- To investigate potential epigenetic regulatory mechanisms.
Main Methods:
- Gene expression analysis using quantitative PCR (qPCR).
- Protein expression analysis via immunohistochemistry.
- Analysis of ccRCC patient samples and cell lines.
Main Results:
- Occludin (OCLN) and Growth Arrest-Specific 1 (GAS1) genes were found to be underexpressed in ccRCC.
- miR-122 and miR-34a were implicated as potential regulators of OCLN and GAS1, respectively.
- Solute Carrier Family 2 Member 1 (SLC2A1) was significantly overexpressed in ccRCC.
Conclusions:
- The identified genes contribute to a deeper understanding of ccRCC's molecular basis.
- Differential expression of OCLN, GAS1, and SLC2A1 highlights their potential roles in ccRCC development.
- This study provides novel insights into the molecular landscape of kidney cancer.
Related Concept Videos
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Abnormal Proliferation
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Regulation of Angiogenesis and Blood Supply

